Crossmark

A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers

Crossref DOI link: https://doi.org/10.1186/s12885-016-2062-2

Published Online: 2016-02-08

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

León-Cachón, Rafael B. R.

Ascacio-Martínez, Jorge A.

Gamino-Peña, María E.

Cerda-Flores, Ricardo M.

Meester, Irene

Gallardo-Blanco, Hugo L.

Gómez-Silva, Magdalena

Piñeyro-Garza, Everardo

Barrera-Saldaña, Hugo A.
License Information

License valid from 2016-02-08